Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second…
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc….
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks…
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial…
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection…
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Featured
Page 2
Featured
Featured posts
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) Amidst Groundbreaking Cancer Therapy Innovations
admin
-
April 1, 2024
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks Investor Excitement”
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial Hypertension
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection Treatments
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of Healthcare Investment (ATNM)
Aggressive Ways to Play the Infrastructure Bill (PXD, VMC, MLM, CEI,...
Gavins Felicity
-
August 4, 2021
0
The Covid Vaccine Market is a Long Game in the Early...
Gavins Felicity
-
August 4, 2021
0
Delta Means Beta Testing Alpha Strategies in Biotech (NVAX, MRNA, DYAI,...
Gavins Felicity
-
July 22, 2021
0
The Inevitable Path to US Legalization? (TLRY, SNDL, NUGS, VFF, CRLBF,...
Gavins Felicity
-
July 22, 2021
0
KULR Ripe for Interest from Thematic ETF Managers Following Uplist? (LIT,...
Gavins Felicity
-
July 14, 2021
0
1
2
3
...
42
Page 2 of 42
Recent Post
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...
Gavins Felicity
-
April 18, 2024
0
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a pioneer in biotechnology, has recently achieved a critical milestone in its fight against acute myeloid leukemia...
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
April 1, 2024
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks...
March 29, 2024
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...
March 26, 2024
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...
March 25, 2024